BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17059786)

  • 1. [A mini-review of targeting gene-virotherapy of cancer].
    Liu XY; Gu JF
    Ai Zheng; 2006 Oct; 25(10):1320-2. PubMed ID: 17059786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gene-virotherapy of cancer.
    Liu XY; Gu JF
    Cell Res; 2006 Jan; 16(1):25-30. PubMed ID: 16467873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting gene-virotherapy of cancer and its prosperity.
    Liu XY
    Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
    Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated cancer gene therapy and virotherapy (Review).
    Fukazawa T; Matsuoka J; Yamatsuji T; Maeda Y; Durbin ML; Naomoto Y
    Int J Mol Med; 2010 Jan; 25(1):3-10. PubMed ID: 19956895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
    Su C; Na M; Chen J; Wang X; Liu Y; Wang W; Zhang Q; Li L; Long J; Liu X; Wu M; Fan X; Qian Q
    Mol Cancer Res; 2008 Apr; 6(4):568-75. PubMed ID: 18344493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
    Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
    Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.
    Schepelmann S; Ogilvie LM; Hedley D; Friedlos F; Martin J; Scanlon I; Chen P; Marais R; Springer CJ
    Cancer Res; 2007 May; 67(10):4949-55. PubMed ID: 17510425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent anti-hepatoma efficacy of HCCS1 via dual tumor-targeting gene-virotherapy strategy.
    Zhang J; Gan Y; Gu J; Hu J; Liu X; Zhao X
    Oncol Rep; 2008 Nov; 20(5):1035-40. PubMed ID: 18949398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
    Thorne SH; Contag CH
    Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice.
    Hung CF; Tsai YC; He L; Coukos G; Fodor I; Qin L; Levitsky H; Wu TC
    Gene Ther; 2007 Jan; 14(1):20-9. PubMed ID: 16915291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines.
    Xie M; Niu JH; Chang Y; Qian QJ; Wu HP; Li LF; Zhang Y; Li JL; Huang XJ; Ruan GR
    Apoptosis; 2009 Sep; 14(9):1086-94. PubMed ID: 19551515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.